Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival

Ellingson, B. M., Wen, P. Y., Chang, S. M., van den Bent, M., Vogelbaum, M. A., Li, G., Li, S., Kim, J., Youssef, G., Wick, W., Lassman, A. B., Gilbert, M. R., de Groot, J. F., Weller, M., Galanis, E., & Cloughesy, T. F. (2023). Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro-Oncology, 25(6), 1017–1028. https://doi.org/10.1093/neuonc/noad002
Authors:
Benjamin M Ellingson
Patrick Y Wen
Susan M Chang
Martin van den Bent
Michael A Vogelbaum
Gang Li
Shanpeng Li
Jiyoon Kim
Gilbert Youssef
Wolfgang Wick
Andrew B Lassman
Mark R Gilbert
John F de Groot
Michael Weller
Evanthia Galanis
Timothy F Cloughesy
Affiliated Authors:
Andrew B Lassman
Columbia Affiliation:
Subjects:
Glioblastoma (MeSH)
Brain Neoplasms (MeSH)
Antineoplastic Agents (MeSH)
Author Keywords:
glioblastoma
objective response rate
overall survival
recurrent gbm
elink
Publication Type:
Article
Unique ID:
10.1093/neuonc/noad002
PMID:
36617262
DOI:
10.1093/neuonc/noad002
Journal:
Neuro-Oncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: